Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages

结核病相关的I型干扰素诱导隧道纳米管上的Siglec-1表达,并促进HIV-1在巨噬细胞中的传播。

阅读:1
作者:Maeva Dupont ,Shanti Souriant # ,Luciana Balboa # ,Thien-Phong Vu Manh ,Karine Pingris ,Stella Rousset ,Céline Cougoule ,Yoann Rombouts ,Renaud Poincloux ,Myriam Ben Neji ,Carolina Allers ,Deepak Kaushal ,Marcelo J Kuroda ,Susana Benet ,Javier Martinez-Picado ,Nuria Izquierdo-Useros ,Maria Del Carmen Sasiain ,Isabelle Maridonneau-Parini # ,Olivier Neyrolles # ,Christel Vérollet # ,Geanncarlo Lugo-Villarino #

Abstract

While tuberculosis (TB) is a risk factor in HIV-1-infected individuals, the mechanisms by which Mycobacterium tuberculosis (Mtb) worsens HIV-1 pathogenesis remain scarce. We showed that HIV-1 infection is exacerbated in macrophages exposed to TB-associated microenvironments due to tunneling nanotube (TNT) formation. To identify molecular factors associated with TNT function, we performed a transcriptomic analysis in these macrophages, and revealed the up-regulation of Siglec-1 receptor. Siglec-1 expression depends on Mtb-induced production of type I interferon (IFN-I). In co-infected non-human primates, Siglec-1 is highly expressed by alveolar macrophages, whose abundance correlates with pathology and activation of IFN-I/STAT1 pathway. Siglec-1 localizes mainly on microtubule-containing TNT that are long and carry HIV-1 cargo. Siglec-1 depletion decreases TNT length, diminishes HIV-1 capture and cell-to-cell transfer, and abrogates the exacerbation of HIV-1 infection induced by Mtb. Altogether, we uncover a deleterious role for Siglec-1 in TB-HIV-1 co-infection and open new avenues to understand TNT biology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。